|
|
|
|
| LEADER |
01400nam a22002775i 4500 |
| 001 |
000292921 |
| 005 |
20210924141123.0 |
| 007 |
cr nn 008mamaa |
| 008 |
171204s2017 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319701424
|
| 024 |
7 |
|
|a 10.1007/978-3-319-70142-4
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Resistance to Targeted Therapies in Breast Cancer /
|c edited by Jenifer R. Prosperi.
|
| 250 |
|
|
|a 1st ed. 2017.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2017.
|
| 300 |
|
|
|a XV, 184 p. 12 illus. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Resistance to Targeted Anti-Cancer Therapeutics,
|v 16
|
| 505 |
0 |
|
|a Invasive Breast Cancer Therapy 2017: How Well Are We Hitting The Target? -- Resistance to HER2-targeted therapy -- Endocrine Resistance and Breast Cancer Stem Cells – The Inflammatory Connection That Could Lead to New and Improved Therapy Outcomes -- EGFR Resistance -- Targeting FGFR for the treatment of breast cancer -- Targeted Therapies in Breast Cancer -- Future paradigm of breast cancer resistance and treatment.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
1 |
4 |
|a Cancer Research.
|
| 700 |
1 |
|
|a Prosperi, Jenifer R.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|